Jury selection starts today in the first trial against Takeda alleging the diabetes drug Actos caused bladder cancer. There are more than 3,000 similar claims pending. The Plaintiff, Jack Cooper, is suffering with bladder cancer and alleges that Takeda’s U. S. unit didn’t adequlately warn potential patients that Actos could cause the disease. The FDA flagged the risk in a new analysis of an Actos trial, which suggested Actos patents faced increased risk of bladder cancer and heart problems. The FDA’s review is ongoing with results expected next year. The agency has already required new warning language on the drug’s label. The Cooper lawsuit is among a group of cases under reiview in the same California state court. Another 1,200 lawsuits are consolidated in an MDL in Louisiana. The first of those cases is set for trial in November 2014.
Author: Sarah Showardhttp://showardlaw.com
Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Women's Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorney, and has been representing plaintiffs since 1990.